Trials / Completed
CompletedNCT02467335
Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A single oral dose study in subjects with hepatic impairment and healthy control subjects. Subjects will stay at the clinical facility where interval blood samplings will be obtained and examined for drug effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-663068 | BMS-663068 |
Timeline
- Start date
- 2015-01-29
- Primary completion
- 2015-10-03
- Completion
- 2015-10-03
- First posted
- 2015-06-10
- Last updated
- 2017-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02467335. Inclusion in this directory is not an endorsement.